Technical Overview
Semax is a synthetic heptapeptide analog of a fragment of the adrenocorticotropic hormone (ACTH 4-10). Developed in the Institute of Molecular Genetics (Russian Academy of Sciences), it is researched for its potent neuroprotective and neurogenic properties. Unlike many stimulants, Semax does not rely on catecholamine depletion, but rather on the modulation of the brain’s internal signaling systems.
The “Cognitive Axis” Research Profile
-
BDNF Upregulation: Studied for its ability to significantly increase levels of Brain-Derived Neurotrophic Factor, essential for neuroplasticity and the survival of existing neurons.
-
Ischemic Protection: Investigated for its ability to protect the brain from oxidative stress and oxygen deprivation.
-
Dopaminergic Modulation: Researched for its role in balancing dopamine and serotonin levels to improve focus and mental endurance.






